Skip to content

The effect of saline lock on prevention of phlebitis

The Effect of Intermittent Normal Saline Flush On Patency of Peripheral Venous Catheter and Prevention of Phlebitis and infiltration: a Single-Blind Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014062118176N1
Enrollment
150
Registered
2014-08-30
Start date
2014-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phlebitis. Vascular complications following infusion, transfusion and therapeutic injection

Interventions

Intervention 1: In the first intervention group, IV catheter, flushed with 3 ml of normal saline every 8 hours for 72 hours, also before and after of any injection. Intervention 2: In the second inter
Treatment - Drugs
Prevention
In the first intervention group, IV catheter, flushed with 3 ml of normal saline every 8 hours for 72 hours, also before and after of any injection.
In the second intervention group, IV catheter, flushed with 3 ml of normal saline every 12 hours for 72 hours, and also before and after of any injection.
control group not receiving the intervention according to current hospital routines.

Sponsors

Research Deputy of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: adult patients (Older than 18 years old) admitted to the medical-surgical wards that will hospitalized at least three days after surgery; patients with peripheral intravenous catheter in the upper limb (on the forearm) and patients who were willing to participate. Exclusion criteria: patients who had any underlying blood disorders (eg, hemophilia, diabetes, etc); patients who receiving anticoagulant therapy (heparin, warfarin, Plavix, etc); patients who receiving IV potassium chloride; patients who receiving continuous intravenous fluid therapy; replacement of the catheter for any reason other than phlebitis; discharged or died during the study period; emergency situation that requires immediate medical or nursing interventions, such as cardiopulmonary resuscitation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Phlebitis. Timepoint: 24-48-72 hours, respectively, after the pre-test. Method of measurement: Visual Analogue Scale phlebitis.

Secondary

MeasureTime frame
Infiltration and the patency of the catheter. Timepoint: respectively, 24-48-72 hours after the pre-test. Method of measurement: Observation checklist and visual analogue scale infiltration.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMorteza Fotowati

Tabriz University of Medical Sciences, Faculty of Nursing and Midwifery

fotowati@gmail.com; fotowati@yahoo.com; fotowatim@tbzmed.ac.ir+98 41 1479 6770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026